Introduction: Ivermectin is a member of avermectins family which was discovered in 1967in Japan. The contribution of this drug to animal and human health was so prominent thatthe researchers who found the drug were awarded a Noble prize in 2015. With the advent ofCOVID-19,lot of interest has shifted more towards ivermectin usage in treating the COVID-19alone or in combination with other medicines as synergism. Since its introduction, ivermectinhas helped to control many parasitic diseases of animals and humans. For many years after itsdiscovery, ivermectin was considered to be only a parasitic agent, but as scientists continue toevaluate this drug, they discover more healing aspects.Materials and Methods: For this review, we searched keywor...
CITATION: Van Rensburg, R. et al. 2021. Ivermectin for COVID-19 : promising but not yet conclusive. ...
In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infecti...
To date, very few treatments have been demonstrated to reduce the burden of morbidity and mortality ...
Introduction: SARS-CoV-2 produces a respiratory syndrome that can range from a mild, self-limiting i...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected almost every country i...
Purpose: Ivermectin is a broad-spectrum antiparasitic and an effective drug to treat COVID-19. In th...
Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wid...
Drug repositioning is a alternative strategy to discover and develop anticancer drugs based on ident...
Introduction: Ivermectin is a commonly used antihelminthic agent with over 35 years of established s...
Discussion of scholarly papers published on Ivermectin, starting from the article of Caly et al. in ...
Objective of the review was to evaluate the effectiveness of Ivermectin as a treatment of COVID-19. ...
Ivermectin is an avermectin which is a group of pentacyclic sixteen-membered lactone (macrocyclic la...
The novel coronavirus infection has spread all over the world. With no specific drug or vaccine, the...
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, ther...
Viral infections remain a major cause of economic loss with an unmet need for novel therapeutic agen...
CITATION: Van Rensburg, R. et al. 2021. Ivermectin for COVID-19 : promising but not yet conclusive. ...
In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infecti...
To date, very few treatments have been demonstrated to reduce the burden of morbidity and mortality ...
Introduction: SARS-CoV-2 produces a respiratory syndrome that can range from a mild, self-limiting i...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected almost every country i...
Purpose: Ivermectin is a broad-spectrum antiparasitic and an effective drug to treat COVID-19. In th...
Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wid...
Drug repositioning is a alternative strategy to discover and develop anticancer drugs based on ident...
Introduction: Ivermectin is a commonly used antihelminthic agent with over 35 years of established s...
Discussion of scholarly papers published on Ivermectin, starting from the article of Caly et al. in ...
Objective of the review was to evaluate the effectiveness of Ivermectin as a treatment of COVID-19. ...
Ivermectin is an avermectin which is a group of pentacyclic sixteen-membered lactone (macrocyclic la...
The novel coronavirus infection has spread all over the world. With no specific drug or vaccine, the...
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, ther...
Viral infections remain a major cause of economic loss with an unmet need for novel therapeutic agen...
CITATION: Van Rensburg, R. et al. 2021. Ivermectin for COVID-19 : promising but not yet conclusive. ...
In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infecti...
To date, very few treatments have been demonstrated to reduce the burden of morbidity and mortality ...